Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.90 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.90 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.25 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.46 | 17505938 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.87 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.84 | 16835633 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.75 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001006 |
Anus, Imperforate |
marker/mechanism |
|
| |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.83 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.88 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.84 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 18558336 17157402 18775368 17507914 18396377 17688650 18940202 20603192 18985861 18316065 19460635 19232924 18177632 16609825 15238991 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.21 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.37 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.65 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.65 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.93 | 19288272 19221464 18984771 19189212 18997820 18351453 17049068 15565566 16818667 18629630 20859285 19155303 21152245 15668708 20390343 18815881 18821012 17893378 17242785 20005174 19011961 18425577 19066611 19103187 19059307 19289846 19084267 20544844 17261762 19142967 19487384 11161223 20065188 19115204 16273361 19189210 21138602 16202921 16873071 20135344 19244106 18855134 19200415 19410462 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.10 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.10 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.92 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 18850075 16120746 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.98 | 6135515 |
MESH:D002547 |
Cerebral Palsy |
marker/mechanism |
|
| |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.80 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
3.10 | 15861022 17681005 16105132 16919318 11677210 17333356 17110522 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.17 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 8697196 12621046 15668235 15340226 16354765 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.55 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
2.55 | 8888407 16575769 17688650 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.44 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.78 | 19031437 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.06 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.76 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.64 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.64 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.64 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
9.64 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.40 | 1851702 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.70 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 16714409 15322242 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.24 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.24 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.24 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.57 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.44 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.07 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.87 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.71 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.53 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.08 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
15.08 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
15.08 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.41 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.41 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.51 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.64 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.31 | 12621046 15340226 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.33 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 16354765 16959395 18606429 8697196 15340226 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18850075 18670907 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.23 | 16945680 16569931 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.81 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.68 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.37 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.37 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.47 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
8.29 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.29 | 18625569 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.37 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.36 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.36 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.97 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.97 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.97 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.34 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.34 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.78 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.32 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.32 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.41 | 14737004 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.22 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.81 | 16827153 19196722 19196723 11731420 14580682 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
5.07 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.91 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.64 | 15990972 |
MESH:D038901 |
Mental Retardation, X-Linked |
marker/mechanism |
|
| |
MESH:D008831 |
Microcephaly |
marker/mechanism |
|
| |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.41 | 18803445 18765137 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.35 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.31 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.32 | 7678174 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.65 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.52 | 19196722 19200415 19189210 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.59 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.32 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.74 | 16049721 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
4.04 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
11.05 | 11118676 11399792 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
11.05 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.22 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.22 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.77 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.06 | 11422049 12752131 |
MESH:C537761 |
Renpenning syndrome 1 |
marker/mechanism |
|
| |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.53 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.63 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
6.63 | 1511512 15475178 3137016 14763951 17978042 16876388 11044598 11738929 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.17 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.36 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.36 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.02 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.06 | 12833885 |
MESH:D013733 |
Testicular Diseases |
marker/mechanism |
|
| |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.97 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.44 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.75 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.98 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.38 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.38 | 8653321 17572228 16712894 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.06 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.78 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.68 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.87 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |